Evaluation and experience from routine use of chemiluminescence assays for serological screening of blood and plasma donations on the Alinity s system and the Alinity i system, two new fully-automated immunoassay systems in Poland

In Poland, independent evaluations under the auspices of the Institute of Hematology and Transfusion Medicine (IHTM) are mandated for any new device, assay, systems for screening samples from whole blood and plasma donors prior to implementation by Blood Transfusion Center (BTC). In last 5 years, tw...

Full description

Bibliographic Details
Main Authors: Aneta Kopacz, Dorota Kubicka-Russel, Grzegorz Liszewski, Alicja Bukowska, Sylwia Samek, Dorota Malka, Magdalena Łętowska, Piotr Grabarczyk
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Practical Laboratory Medicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352551724000106
_version_ 1797326257244864512
author Aneta Kopacz
Dorota Kubicka-Russel
Grzegorz Liszewski
Alicja Bukowska
Sylwia Samek
Dorota Malka
Magdalena Łętowska
Piotr Grabarczyk
author_facet Aneta Kopacz
Dorota Kubicka-Russel
Grzegorz Liszewski
Alicja Bukowska
Sylwia Samek
Dorota Malka
Magdalena Łętowska
Piotr Grabarczyk
author_sort Aneta Kopacz
collection DOAJ
description In Poland, independent evaluations under the auspices of the Institute of Hematology and Transfusion Medicine (IHTM) are mandated for any new device, assay, systems for screening samples from whole blood and plasma donors prior to implementation by Blood Transfusion Center (BTC). In last 5 years, two new systems were introduced to the market by Abbott GmbH, namely the Alinity s and the Alinity i. The evaluations performed for these two systems included the assessment of sensitivity, specificity and precision for each of the four mandatory serological screening markers in Poland: Hepatitis B Surface Antigen (HBsAg), Hepatitis C virus antibodies (Anti-HCV), HIV antibodies (anti-HIV) and Syphilis antibodies (anti-Treponema pallidum, anti-TP). Sensitivity was assessed by testing seroconversion panels, HBsAg international reference standard, well characterized local samples, and dilution panels. Specificity was assessed by testing routine donor samples. The results from Alinity i assays were compared to the results from Abbott ARCHITECT i2000SR and Ortho VITROS 3600 assays, while the results from Alinity s assays were compared to the results of ARCHITECT i2000SR assays. The evaluation of the Alinity s and Alinity i assays for sensitivity (100 %), specificity (99,92–100 %) and precision generated results that were as good as or better than generated by routinely used systems, were within acceptance criteria, and met all requirements for screening blood donor samples in accordance with Polish regulations. The specificity of the assays in routine use by BTCs, analyzed after approximately 150,000 donations on both systems, was comparable to the specificity observed during the evaluations at IHTM.
first_indexed 2024-03-08T06:21:47Z
format Article
id doaj.art-d6dbddc6b2eb4c85b0af4d24e6e2c04e
institution Directory Open Access Journal
issn 2352-5517
language English
last_indexed 2024-03-08T06:21:47Z
publishDate 2024-03-01
publisher Elsevier
record_format Article
series Practical Laboratory Medicine
spelling doaj.art-d6dbddc6b2eb4c85b0af4d24e6e2c04e2024-02-04T04:45:19ZengElsevierPractical Laboratory Medicine2352-55172024-03-0139e00364Evaluation and experience from routine use of chemiluminescence assays for serological screening of blood and plasma donations on the Alinity s system and the Alinity i system, two new fully-automated immunoassay systems in PolandAneta Kopacz0Dorota Kubicka-Russel1Grzegorz Liszewski2Alicja Bukowska3Sylwia Samek4Dorota Malka5Magdalena Łętowska6Piotr Grabarczyk7Institute of Hematology and Transfusion Medicine (IHTM), Department of Virology, Warsaw, Poland; Corresponding author. Department of Virology, Institute of Hematology and Transfusion Medicine, 14 Indiry Gandhi Str, 02-776, Warsaw, Poland.Institute of Hematology and Transfusion Medicine (IHTM), Department of Virology, Warsaw, PolandInstitute of Hematology and Transfusion Medicine (IHTM), Department of Virology, Warsaw, PolandRegional Blood Transfusion Center, Poznań, PolandRegional Blood Transfusion Center, Kielce, PolandRegional Blood Transfusion Center, Warsaw, PolandInstitute of Hematology and Transfusion Medicine (IHTM), Department of Virology, Warsaw, PolandInstitute of Hematology and Transfusion Medicine (IHTM), Department of Virology, Warsaw, PolandIn Poland, independent evaluations under the auspices of the Institute of Hematology and Transfusion Medicine (IHTM) are mandated for any new device, assay, systems for screening samples from whole blood and plasma donors prior to implementation by Blood Transfusion Center (BTC). In last 5 years, two new systems were introduced to the market by Abbott GmbH, namely the Alinity s and the Alinity i. The evaluations performed for these two systems included the assessment of sensitivity, specificity and precision for each of the four mandatory serological screening markers in Poland: Hepatitis B Surface Antigen (HBsAg), Hepatitis C virus antibodies (Anti-HCV), HIV antibodies (anti-HIV) and Syphilis antibodies (anti-Treponema pallidum, anti-TP). Sensitivity was assessed by testing seroconversion panels, HBsAg international reference standard, well characterized local samples, and dilution panels. Specificity was assessed by testing routine donor samples. The results from Alinity i assays were compared to the results from Abbott ARCHITECT i2000SR and Ortho VITROS 3600 assays, while the results from Alinity s assays were compared to the results of ARCHITECT i2000SR assays. The evaluation of the Alinity s and Alinity i assays for sensitivity (100 %), specificity (99,92–100 %) and precision generated results that were as good as or better than generated by routinely used systems, were within acceptance criteria, and met all requirements for screening blood donor samples in accordance with Polish regulations. The specificity of the assays in routine use by BTCs, analyzed after approximately 150,000 donations on both systems, was comparable to the specificity observed during the evaluations at IHTM.http://www.sciencedirect.com/science/article/pii/S2352551724000106Blood donor screeningAlinity systemChemiluminescencePerformance evaluation
spellingShingle Aneta Kopacz
Dorota Kubicka-Russel
Grzegorz Liszewski
Alicja Bukowska
Sylwia Samek
Dorota Malka
Magdalena Łętowska
Piotr Grabarczyk
Evaluation and experience from routine use of chemiluminescence assays for serological screening of blood and plasma donations on the Alinity s system and the Alinity i system, two new fully-automated immunoassay systems in Poland
Practical Laboratory Medicine
Blood donor screening
Alinity system
Chemiluminescence
Performance evaluation
title Evaluation and experience from routine use of chemiluminescence assays for serological screening of blood and plasma donations on the Alinity s system and the Alinity i system, two new fully-automated immunoassay systems in Poland
title_full Evaluation and experience from routine use of chemiluminescence assays for serological screening of blood and plasma donations on the Alinity s system and the Alinity i system, two new fully-automated immunoassay systems in Poland
title_fullStr Evaluation and experience from routine use of chemiluminescence assays for serological screening of blood and plasma donations on the Alinity s system and the Alinity i system, two new fully-automated immunoassay systems in Poland
title_full_unstemmed Evaluation and experience from routine use of chemiluminescence assays for serological screening of blood and plasma donations on the Alinity s system and the Alinity i system, two new fully-automated immunoassay systems in Poland
title_short Evaluation and experience from routine use of chemiluminescence assays for serological screening of blood and plasma donations on the Alinity s system and the Alinity i system, two new fully-automated immunoassay systems in Poland
title_sort evaluation and experience from routine use of chemiluminescence assays for serological screening of blood and plasma donations on the alinity s system and the alinity i system two new fully automated immunoassay systems in poland
topic Blood donor screening
Alinity system
Chemiluminescence
Performance evaluation
url http://www.sciencedirect.com/science/article/pii/S2352551724000106
work_keys_str_mv AT anetakopacz evaluationandexperiencefromroutineuseofchemiluminescenceassaysforserologicalscreeningofbloodandplasmadonationsonthealinityssystemandthealinityisystemtwonewfullyautomatedimmunoassaysystemsinpoland
AT dorotakubickarussel evaluationandexperiencefromroutineuseofchemiluminescenceassaysforserologicalscreeningofbloodandplasmadonationsonthealinityssystemandthealinityisystemtwonewfullyautomatedimmunoassaysystemsinpoland
AT grzegorzliszewski evaluationandexperiencefromroutineuseofchemiluminescenceassaysforserologicalscreeningofbloodandplasmadonationsonthealinityssystemandthealinityisystemtwonewfullyautomatedimmunoassaysystemsinpoland
AT alicjabukowska evaluationandexperiencefromroutineuseofchemiluminescenceassaysforserologicalscreeningofbloodandplasmadonationsonthealinityssystemandthealinityisystemtwonewfullyautomatedimmunoassaysystemsinpoland
AT sylwiasamek evaluationandexperiencefromroutineuseofchemiluminescenceassaysforserologicalscreeningofbloodandplasmadonationsonthealinityssystemandthealinityisystemtwonewfullyautomatedimmunoassaysystemsinpoland
AT dorotamalka evaluationandexperiencefromroutineuseofchemiluminescenceassaysforserologicalscreeningofbloodandplasmadonationsonthealinityssystemandthealinityisystemtwonewfullyautomatedimmunoassaysystemsinpoland
AT magdalenałetowska evaluationandexperiencefromroutineuseofchemiluminescenceassaysforserologicalscreeningofbloodandplasmadonationsonthealinityssystemandthealinityisystemtwonewfullyautomatedimmunoassaysystemsinpoland
AT piotrgrabarczyk evaluationandexperiencefromroutineuseofchemiluminescenceassaysforserologicalscreeningofbloodandplasmadonationsonthealinityssystemandthealinityisystemtwonewfullyautomatedimmunoassaysystemsinpoland